Hong Kong Life Sciences and Technologies Group Limited announced unaudited consolidated financial results for the quarter and nine months ended December 31, 2017. For the quarter, the company reported revenues of HKD 5,438,000 against HKD 43,859,000 a year ago. Loss before tax was HKD 2,335,000 against HKD 658,000 a year ago. Loss for the period was HKD 2,335,000 against HKD 1,210,000 a year ago. Loss for the period attributable to owners of the Company was HKD 2,307,000 against profit for the period attributable to owners of the Company of HKD 409,000 a year ago. Loss per share: basic and diluted were 0.04 cents against EPS of 0.01 cents a year ago. For nine months, the company reported revenues of HKD 92,398,000 against HKD 109,033,000 a year ago. Loss before tax was HKD 3,877,000 against HKD 5,783,000 a year ago. Loss for the period was HKD 3,877,000 against HKD 6,841,000 a year ago. Loss for the period attributable to owners of the Company was HKD 3,059,000 against HKD 1,903,000 a year ago. Loss per share: basic and diluted were 0.05 cents against 0.04 cents a year ago.